1)Mangram AJ, Horan TC, Pearson ML, et al:Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250-278;quiz 279-280, 1999
2)Shinkawa H, Tanaka S, Takemura S, et al:Predictive Value of the Age-Adjusted Charlson Comorbidity Index for Outcomes After Hepatic Resection of Hepatocellular Carcinoma. World J Surg 44:3901-3914, 2020
3)Kinoshita M, Shinkawa H, Kabata D, et al:Impact of Advancing Age on the Status and Risk of Postoperative Infections After Liver Resection. World J Surg 45:3386-3394, 2021
4)坂本和彦,岡田敏正,為佐卓夫,他.肝臓外科領域における術後感染症の危険因子とその対策:日消外会誌40:362-369,2007
5)Yeh DC, Wu CC, Ho WM, et al:Bacterial translocation after cirrhotic liver resection:a clinical investigation of 181 patients. J Surg Res 111:209-214, 2003
6)Kubo S, Tsukamoto T, Hirohashi K, et al:Correlation between preoperative serum concentration of typeⅣcollage 7S domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 239:186-193, 2004
7)Fan ST, Lo CM, Lai EC, et al:Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 331:1547-1552, 1994
8)土師誠二,大柳治正:脂質代謝のup to date肝切除周術期におけるimmunonutritionとしての脂肪投与.外科と代謝・栄養44:111-118,2010
9)Togo S, Matsuo K, Tanaka K, et al:Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol 22:1942-1948, 2007
10)Margonis GA, Amini N, Sasaki K, et al:Perioperative hyperglycemia and postoperative outcomes in patients undergoing resection of colorectal liver metastases. J Gastrointest Surg 21:228-237, 2017
11)日本外科感染症学会消化器外科SSI予防のための周術期管理ガイドライン作成委員会:消化器外科SSI予防のための周術期管理ガイドライン2018.診断と治療社,2018,pp 39-43
12)Kalra L, Camacho F, Whitener CJ, et al:Risk of methicillin-resistant staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. Am J Infect Control 41:1253-1257, 2013
13)MRSA感染症の治療ガイドライン作成委員会(編):MRSA感染症の治療ガイドライン改訂版2019.日本化学療法学会・日本感染症学会,2019,p 115
14)山下千鶴:周術期感染対策Update総論 術前処置・術中消毒法.外科82:1-6,2020
15)Reissfelder C, Brand K, Sobiegalla J, et al:Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases. Surgery 155:245-254, 2014
16)Ishizawa T, Zuker NB, Conrad C, et al:Using a ‘no drain' policy in 342 laparoscopic hepatectomies:which factors predict failure? HPB 16:494-499, 2014
17)Nakano H, Oussoultzoglou E, Rosso E, et al:Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118-124, 2008
18)Kishi Y, Zorzi D, Contreras CM, et al:Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17:2870-2876, 2010
19)生田真一,相原 司,木村文彦,他:術後感染性合併症に対する術前化学療法の影響 大腸癌肝転移切除例.日本外科感染症学会雑誌15:7-14,2018
20)伊藤得路,新川寛二,竹村茂一,他:ポピドンヨードと比較した肝切除術における術前皮膚消毒剤としてのオラネキシジングルコン酸塩の手術部位感染予防効果の検討.日本外科感染症学会雑誌17:503-508,2020
21)日本化学療法学会,日本外科感染症学会(編):術後感染予防抗菌薬適正使用のための実践ガイドライン追補版.日本化学療法学会,日本外科感染症学会,2021
22)Shirata C, Hasegawa K, Kokudo T, et al:Surgical Site Infection after Hepatectomy for Hepatocellular Carcinoma. Dig Surg 35:204-211, 2018
23)Kaibori M, Shimizu J, Hayashi M, et al:Late-onset bile leakage after hepatic resection. Surgery 157:37-44, 2015
24)田中肖吾,竹村茂一,新川寛二,他:肝切除術における胆汁漏と手術部位感染.日外感染症会誌15:77-84,2018
25)一般社団法人 日本肝臓学会(編):肝癌診療ガイドライン2017年版,金原出版,2017,pp 122-123
26)久保正二,野沢彰紀,竹村茂一,他:術後合併症からみた肝切除術における腹腔ドレーンの意義.日外感染症会誌10:375-381,2013
27)Shirai D, Shinkawa H, Kabata D, et al:Laparoscopic liver resection reduces postoperative infection in patients with hepatocellular carcinoma:a propensity score-based analysis. Surg Endosc 2022 Jul 15.